Search Result "Ceritinib"
Enteral Administration of TKIs: Report of a Response to Ceritinib in an ALK-positive NSCLC Patient and Literature Review
Journal: Current Drug Targets
Volume: 19 Issue: 14 Year: 2018 Page: 1649-1656
Author(s): Francesco Facchinetti,Paola Bordi,Paola Bini,Livia Bidin,Roberta Camisa,Marcello Tiseo
Current Strategies to Overcome Resistance to ALK-Inhibitor Agents
Journal: Current Drug Metabolism
Volume: 16 Issue: 7 Year: 2015 Page: 585-596
Author(s): Francesca Simionato,Melissa Frizziero,Carmine Carbone,Giampaolo Tortora,Davide Melisi
Anaplastic Lymphoma Kinase Inhibitors in Non-Small Cell Lung Cancer
Journal: Current Drug Targets
Volume: 17 Issue: 6 Year: 2016 Page: 739-745
Author(s): David M. Straughan, Sa d C. Azoury, Vivek Shukla
Resistance to Crizotinib in Advanced Non-Small Cell Lung Cancer (NSCLC) with ALK Rearrangement: Mechanisms, Treatment Strategies and New Targeted Therapies
Journal: Current Clinical Pharmacology
Volume: 11 Issue: 2 Year: 2016 Page: 77-87
Author(s): Francesca Casaluce,Assunta Sgambato,Paola Claudia Sacco,Giovanni Palazzolo,Paolo Maione,Antonio Rossi,Fortunato Ciardiello,Cesare Gridelli
EGFR and EML4-ALK Updated Therapies in Non-Small Cell Lung Cancer
Journal: Recent Patents on Anti-Cancer Drug Discovery
Volume: 11 Issue: 4 Year: 2016 Page: 393-400
Author(s): Ramon Andrade De Mello,Davi J. J. Liu,Pedro N. Aguiar,Hakaru Tadokoro
A Comprehensive Review of the Pharmacologic Perspective on Loop Diuretic DrugInteractions with Therapeutically Used Drugs
Journal: Current Drug Metabolism
Volume: 23 Issue: 3 Year: 2022 Page: 188-199
Author(s): Naina Mohamed Pakkir Maideen
Polypharmacology in Precision Oncology: Current Applications and Future Prospects
Journal: Current Pharmaceutical Design
Volume: 22 Issue: 46 Year: 2016 Page: 6935-6945
Author(s): Albert A. Antolin,Paul Workman,Jordi Mestres,Bissan Al-Lazikani
Research Progress on the Drug Resistance of ALK Kinase Inhibitors
Journal: Current Medicinal Chemistry
Volume: 29 Issue: 14 Year: 2022 Page: 2456-2475
Author(s): Zhen Li,Fang Liu,Shuang Wu,Shi Ding,Ye Chen
Prospecting for New Inhibitors of Anaplastic Lymphoma Kinase, A Clinically Relevant Oncogenic Drug Target
Journal: Current Bioactive Compounds
Volume: 13 Issue: 3 Year: 2017 Page: 236-243
Author(s): Daniel F. Kawano,Carlton A. Taft,Carlos H.T.P. da Silva
Design, Synthesis, and In vitro Anticancer Activity of Novel ChrysinDerivatives
Journal: Letters in Drug Design & Discovery
Volume: 20 Issue: 7 Year: 2023 Page: 854-862
Author(s):